Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Feb 11, 2026 · 10-K · 42 days after period end · 0001640334-26-000241
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $360.00K |
| Net Income | $42.53K | -$10.67K | -$18.24K | -$3.93M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 11, 2026 · 42 d after period end
